AAAAAA

   
Results: 1-3 |
Results: 3
Cotreatment with STI-571 enhances tumor necrosis factor alpha-related apoptosis-inducing ligand (TRAIL or Apo-2L)-induced apoptosis of Bcr-Abl-positive human acute leukemia cells
Authors: Nimmanapalli, R Porosnicu, M Nguyen, D Worthington, E O'Bryan, E Perkins, C Bhalla, K
Citation: R. Nimmanapalli et al., Cotreatment with STI-571 enhances tumor necrosis factor alpha-related apoptosis-inducing ligand (TRAIL or Apo-2L)-induced apoptosis of Bcr-Abl-positive human acute leukemia cells, CLIN CANC R, 7(2), 2001, pp. 350-357
Co-treatment with As2O3 enhances selective cytotoxic effects of STI-571 against Bcr-Abl-positive acute leukemia cells
Authors: Porosnicu, M Nimmanapalli, R Nguyen, D Worthington, E Perkins, C Bhalla, KN
Citation: M. Porosnicu et al., Co-treatment with As2O3 enhances selective cytotoxic effects of STI-571 against Bcr-Abl-positive acute leukemia cells, LEUKEMIA, 15(5), 2001, pp. 772-778
Oncolytic activity of vesicular stomatitis virus is effective against tumors exhibiting aberrant p53, Ras, or Myc function and involves the inductionof apoptosis
Authors: Balachandran, S Porosnicu, M Barber, GN
Citation: S. Balachandran et al., Oncolytic activity of vesicular stomatitis virus is effective against tumors exhibiting aberrant p53, Ras, or Myc function and involves the inductionof apoptosis, J VIROLOGY, 75(7), 2001, pp. 3474-3479
Risultati: 1-3 |